BioSpace News Archive

Protagonist Therapeutics, Inc. , today announced the closing of its previously announced underwritten public offering of 3,503,311 shares of its common stock.

Kala Pharmaceuticals, Inc., announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635.

According to The Insight Partners market research study of Continuous Positive Airway Pressure (CPAP) Devices Market to2027 - Global Analysis and Forecast by Type and End User, the global continuous positive airway pressure (CPAP) devices market is expected to reach US$ 4,481.41 million by2027 from US$ 2,462.86 million in 2019.

Ocugen, Inc. announced the Compensation Committee of the Board of Directors of Ocugen approved the grant of stock options to purchase an aggregate of 157,450 shares of its common stock and restricted stock units covering an aggregate of 26,300 shares of common stock to four new employees.

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), today announced the closing of its previously announced underwritten public offering of 15 million shares of its common stock at a price to the public of $3.00 per share.

The increasing cases of urea cycle disorder is a key factor augmenting the growth of the global urea cycle disorders treatment market during the forecast period, set between 2020 and 2030.

The two US-based board members of Nordic Nanovector ASA, Joanna Horobin and Jean-Pierre Bizzari have resolved to settle a total number of 22,860 RSUs that were issued to them in June 2020 after they had elected to receive all or part of their remuneration for the period from the annual general meeting in 2020 to the annual general meeting in 2021 in RSUs.

Acellular dermal matrices have gained popularity in implant-based breast procedures, most notably in aesthetic breast reconstructions.

The single-use bioprocessing probes and sensors market may harness promising growth across the assessment period of 2019-2029.

An extensive variety of medicinal services associations and establishments are receiving healthcare workforce managements systems so as to defeat administration issues.